ANGARUS THERAPEUTICS
Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patients with a wide range of cancer treatments. Chih-Ping Liu established the company in Sunnyvale, California in 2018.
ANGARUS THERAPEUTICS
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.angarustherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
650-575-1702
Total Funding:
11.32 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Medisyn Technologies
Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
Foothill Ventures
Foothill Ventures investment in Venture Round - Angarus Therapeutics
Official Site Inspections
http://www.angarustherapeutics.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Angarus Therapeutics"
Angarus Therapeutics
Unraveling the complexities of immune-surveillance and immunosuppressive pathways and the associated molecular targets is not an easy task. In collaboration with scientists from Stanford University, our efforts have enabled โฆSee details»
Angarus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Nov 1, 2024 www.angarustherapeutics.com. Startups | Holding Company | 2018 | California, United States | 50-100 | www.angarustherapeutics.com. Last update 01 Nov 2024. Overview. โฆSee details»
Angarus Therapeutics - LinkedIn
At Angarus, we are developing a new class of therapeutics that selectively targets immune-activating and immunosuppressive pathways within the tumor microenvironment, using predictive biomarkers ...See details»
Angarus Therapeutics Company Profile 2024: โฆ
Angarus Therapeutics General Information Description. Developer of immuno-oncology therapies designed to respond to the urgent needs of cancer treatment. The company's therapies develop checkpoint blockers on the innate immunity โฆSee details»
Who We Are - Angarus Therapeutics
Ed Schnipper, M.D. Acting Chief Medical Officer. Ed is a widely recognized expert in innovative design and management of clinical trials. He is particularly skilled at clinical trials designed to determine quickly and efficiently whether a drug is โฆSee details»
Angarus Therapeutics Overview | SignalHire Company Profile
Organization Website: angarustherapeutics.com : Angarus Therapeutics industries Biotech: Angarus Therapeutics Employees Size 100-200 employees: Founded: 2018: Angarus โฆSee details»
About - Angarus Therapeutics
Angarus has developed potent and selective small molecule inhibitors of ENPP1 and other ectonucleotidases that modulate tumor immune activity, halting tumor growth and preventing metastases, both alone and in combination with โฆSee details»
Angarus Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Angarus Therapeutics - Overview, News & Similar companies
Popular Searches Angarus Therapeutics Angarus Therapeutics Inc Renesis Therapeutics Inc Angarustherapeutics SIC Code 87,873 NAICS Code 54,541 Show more. Angarus โฆSee details»
Angarus Therapeutics - Contacts, Employees, Board Members, โฆ
Angarus Therapeutics enhances immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.See details»
Angarus Therapeutics โ Funding, Valuation, Investors, News
Information about Angarus Therapeutics is updated every day. Angarus Therapeutics valuation, number of raised finances, contact details, names of founders, latest news.See details»
Angarus Therapeutics - Products, Competitors, Financials, โฆ
Angarustherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Unattributed | Alive. Total Raised $11.32M. Last Raised $11.32M | 3 yrs ago. About Angarus โฆSee details»
ANGUS THERAPEUTICS
Contact LOCATION 6 River Dr, Angus, ON L0M 1B2 โ CONTACT (705)424-8824See details»
Angarus Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 29, 2020: Venture Round - โฆSee details»
Angarus Therapeutics Stock Price, Funding, Valuation, Revenue ...
See Angarus Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Angarus Therapeutics's post-money valuation and revenue.See details»
Science - Angarus Therapeutics
Reducing extracellular adenosine, an immunosuppressor that drives tumor progression and enables tumor cells to escape the immune system. Inhibition of extracellular adenosine โฆSee details»
Angarus Therapeutics, Inc. (Angarus Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
ไบ่งฃAngarus Therapeutics, Inc. (Angarus Therapeutics, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1็ฏๆฐ้ป๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๅ ็ซ็ณป็ป็พ็ ๏ผๆๆฏๅนณๅฐ:ๅฐๅๅญๅ่ฏ๏ผๆช็ฅ๏ผ่ฏ โฆSee details»
Angarus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Angarus Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Neoplasms, Immune System Diseases, Technology ...See details»
Angarus Therapeutics Careers - Levels.fyi
Angarus is a company developing targeted cancer therapies that focus on immune-activating and immunosuppressive pathways within the tumor microenvironment.See details»